2026 ASCO Breast Cancer Highlights: BWEL - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

2026 ASCO Breast Cancer Highlights: BWEL

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.

  • October 15, 2026

Share

Objective:

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD, discuss research from the Breast Cancer Weight Loss (BWEL) trial and recommendations concerning lifestyle, diet, and GLP-1 agonists.

Interpretation:

The supplied context identifies the discussion topics but provides no transcript or study findings, so specific results and recommendations cannot be summarized.

Limitations:
  • The supplied context contains no transcript, methods, results, or specific recommendations.

Original Source(s)

2026 ASCO Breast Cancer Highlights: BWEL

  • October 15, 2026

Related Content

2026 ASCO Breast Cancer Highlights: Triple Negative Breast Cancer

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new antibody drug conjugate treatment options in first line triple negative breast cancer.

  • October 15, 2026

  • 1 min
Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

Outcomes for American Indian and Alaska Native Populations With Cancer in Traditional Medicare